Pascal Leblanc

Pascal Leblanc serves as a Principal Investigator at the Institut NeuroMyoGène-INMG since 2016 and has held a similar position at CNRS since 2001. With expertise in neurodegenerative disorders, particularly prion diseases and amyotrophic lateral sclerosis, as well as aging and degenerative disorders such as inclusion body myositis, Pascal Leblanc investigates the antiviral properties of cellular prion proteins and their interactions with retroviruses, including HIV-1 and MuLV. Additional research includes studying prion and exosome interactions. Prior roles include a scientific position at ENS Lyon since 1999 and a postdoctoral fellowship at INSERM from 1994 to 2001, where investigations focused on host-pathogen interactions. Pascal Leblanc holds a PhD in transposable elements, retrotransposons, and retroviruses from Université d'Auvergne and completed earlier studies leading to a DEUG to DEA degree at Université Blaise Pascal.